Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dr Reddy's Laboratories

13.66
-0.0150-0.11%
Volume:756.17K
Turnover:10.35M
Market Cap:11.38B
PE:18.16
High:13.77
Open:13.72
Low:13.63
Close:13.67
Loading ...

Bausch (BHC) Moves 13.3% Higher: Will This Strength Last?

Zacks
·
Yesterday

Dr. Reddy's Laboratories Climbs Monday, Underperforms Competitors

Dow Jones
·
Yesterday

Investing in ReadyTech Holdings (ASX:RDY) five years ago would have delivered you a 56% gain

Simply Wall St.
·
Yesterday

Dr. Reddy’s says report of 25% workforce cost reduction ‘incorrect’

TIPRANKS
·
15 Apr

Dr Reddy's Says Reported Job Cuts 'Factually Incorrect'

MT Newswires Live
·
15 Apr

Dr. Reddy’s Laboratories (RDY): Among the Best Indian Stocks to Buy According to Billionaires

Insider Monkey
·
14 Apr

Asian Equities Traded in the US as American Depositary Receipts Tumble in Thursday Trading

MT Newswires Live
·
10 Apr

Asian Equities Traded in the US as American Depositary Receipts Sharply Lower in Monday Trading

MT Newswires Live
·
07 Apr

Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading

MT Newswires Live
·
03 Apr

Dr. Reddy's Signs Commercialization, License Deals for Bio-Thera Biosimilars in Southeast Asia

MT Newswires Live
·
28 Mar

Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia

PR Newswire
·
27 Mar

Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

MT Newswires Live
·
27 Mar

Dr. Reddy's Laboratories Currently Up Eight Consecutive Days, on Track for Longest Winning Streak Since March 2019 -- Data Talk

Dow Jones
·
25 Mar

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
20 Mar

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review

Zacks
·
19 Mar

Asian Equities Traded in the US as American Depositary Receipts Track Sharply Lower in Tuesday Trading

MT Newswires Live
·
18 Mar

Dr. Reddy's, Alvotech Say FDA Accepts Biologic License Application for Bone Drug Biosimilar

MT Newswires Live
·
18 Mar

Dr. Reddy’s, Alvotech announce FDA acceptance of BLA for AVT03

TIPRANKS
·
18 Mar

Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

GlobeNewswire
·
18 Mar

Asian Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher

MT Newswires Live
·
17 Mar